Search Within

Larry Norton

Formats
  1. Journal Article (411)
  2. Meeting Abstract (297)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (762)
  2. Breast Medicine Service (762)
  3. Department of Medicine (762)
  4. Solid Tumor Oncology Division (762)
  5. Survivorship Research (393)
  6. GSK Faculty (224)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (115)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (90)
  6. Hannah Wen (83)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (31)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (160)
  2. American Association for Cancer Research (125)
  3. Nature Publishing Group (77)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (43)

More Publishers

Results (762)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Journal Article

    Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • p21CIP1 promotes mammary cancer-initiating cells via activation of Wnt/TCF1/CyclinD1 signaling
    Journal Article

    Benard, O.; Qian, X.; Liang, H.; Ren, Z.; Suyama, K.; Norton, L.; Hazan, R. B.
    Molecular Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastases
    Journal Article

    Morikawa, A.; de Stanchina, E.; Pentsova, E.; Kemeny, M. M.; Li, B. T.; Tang, K.; Patil, S.; Fleisher, M.; Van Poznak, C.; Norton, L.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia
    Journal Article

    Freites-Martinez, A.; Chan, D.; Sibaud, V.; Shapiro, J.; Fabbrocini, G.; Tosti, A.; Cho, J.; Goldfarb, S.; Modi, S.; Gajria, D.; more...
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • Control and the analysis of cancer growth models
    Journal Article

    Tannenbaum, A.; Georgiou, T. T.; Deasy, J. O.; Norton, L.
    Operator Theory: Advances and Applications (2019)

    Fulltext@MSK | Save
  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: A patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials
    Journal Article

    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
    Lancet (2019)

    Fulltext@MSK | Save
  • Reply to “Multicentric ipsilateral invasive breast carcinomas might have higher 21-gene recurrence score compared with multifocal ipsilateral invasive breast carcinomas”
    Correspondence

    Grabenstetter, A.; Brogi, E.; Chou, J.; Morrow, M.; Dickler, M.; Norton, L.; Wen, H.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Multifocal/multicentric ipsilateral invasive breast carcinomas with similar histology: Is multigene testing of all individual foci necessary?
    Journal Article

    Grabenstetter, A.; Brogi, E.; Chou, J. F.; Morrow, M.; Dickler, M.; Norton, L.; Wen, H. Y.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer with central nervous system metastases
    Meeting Abstract

    Morikawa, A.; Pentsova, E.; Kemeny, M.; Patil, S.; Li, B. T.; Tang, K.; Fleisher, M.; Van Poznak, C. H.; Norton, L.; Seidman, A. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save